- Home
- DCOM vs CLDX Comparison
DCOM vs CLDX Comparison
Compare DCOM & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCOM
- CLDX
- Stock Information
- Founded
- DCOM 1864
- CLDX 1983
- Country
- DCOM United States
- CLDX United States
- Employees
- DCOM N/A
- CLDX N/A
- Industry
- DCOM Major Banks
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- DCOM Finance
- CLDX Health Care
- Exchange
- DCOM Nasdaq
- CLDX Nasdaq
- Market Cap
- DCOM 1.6B
- CLDX 1.8B
- IPO Year
- DCOM 1996
- CLDX 2008
- Fundamental
- Price
- DCOM $33.96
- CLDX $26.04
- Analyst Decision
- DCOM Buy
- CLDX Buy
- Analyst Count
- DCOM 6
- CLDX 8
- Target Price
- DCOM $33.50
- CLDX $64.83
- AVG Volume (30 Days)
- DCOM 285.2K
- CLDX 992.8K
- Earning Date
- DCOM 01-24-2025
- CLDX 11-06-2024
- Dividend Yield
- DCOM 2.95%
- CLDX N/A
- EPS Growth
- DCOM N/A
- CLDX N/A
- EPS
- DCOM 1.50
- CLDX N/A
- Revenue
- DCOM $313,737,000.00
- CLDX $9,976,000.00
- Revenue This Year
- DCOM N/A
- CLDX N/A
- Revenue Next Year
- DCOM $29.45
- CLDX N/A
- P/E Ratio
- DCOM $22.59
- CLDX N/A
- Revenue Growth
- DCOM N/A
- CLDX 128.55
- 52 Week Low
- DCOM $17.29
- CLDX $22.93
- 52 Week High
- DCOM $37.60
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- DCOM 46.61
- CLDX 46.00
- Support Level
- DCOM $33.48
- CLDX $24.48
- Resistance Level
- DCOM $35.79
- CLDX $26.66
- Average True Range (ATR)
- DCOM 1.14
- CLDX 1.24
- MACD
- DCOM -0.40
- CLDX 0.04
- Stochastic Oscillator
- DCOM 13.15
- CLDX 37.41
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. It gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, as well as mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.